文献速递关节外科骨肿瘤

癌症患者全膝关节置换术五年结局

The Five-Year Outcomes of Total Knee Arthroplasty in Patients Who Have Cancer.
PubMed 文献 · J Arthroplasty · 2026-02-06

这项回顾性队列研究基于大型国家数据库,比较有癌症病史与无癌症病史患者全膝关节置换术(TKA)后五年结局。倾向评分1:1匹配后每组8709例,癌症组假体感染、无菌性松动和僵硬的风险显著更高,其他并发症无显著差异。

要点

  • 癌症病史患者TKA术后五年假体感染风险显著升高(OR 1.22, 95%CI 1.00–1.48)。
  • 癌症病史患者无菌性松动风险显著升高(OR 1.36, 95%CI 1.00–1.83)。
  • 癌症病史患者僵硬风险显著升高(OR 1.56, 95%CI 1.34–1.81),其他并发症无显著差异。

核心结论

  • 癌症病史与TKA术后五年假体周围感染、无菌性松动和僵硬风险增加相关。
  • 需对该高风险人群进行个体化围手术期优化、感染预防和结构化长期监测。

研究设计与样本

  • 回顾性队列分析,使用大型国家数据库,纳入2002年7月至2020年7月接受TKA的所有成年患者。
  • 按手术时癌症病史分组,倾向评分1:1匹配后每组8709例。

主要发现

  • 五年时癌症组假体感染发生率为2.60%,对照组为2.10%(OR 1.22, 95%CI 1.00–1.48)。
  • 癌症组无菌性松动发生率为1.10%,对照组为0.80%(OR 1.36, 95%CI 1.00–1.83)。
  • 癌症组僵硬发生率为5.00%,对照组为3.30%(OR 1.56, 95%CI 1.34–1.81)。
  • 其他并发症(假体周围骨折、不稳定、骨溶解、聚乙烯磨损、异位骨化等)无显著差异。

关键数值与推荐

  • 主要结局为五年时假体周围骨折、感染、无菌性松动、不稳定、骨溶解、聚乙烯磨损、骨化性肌炎、假体所致疼痛、假体所致纤维化、异位骨化、僵硬等。
  • 计算比值比(OR)及95%置信区间(CI)。

临床怎么用

  • 对癌症病史患者TKA术后应加强感染预防措施。
  • 对癌症病史患者TKA术后应进行结构化长期监测,关注假体感染、无菌性松动和僵硬。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Cancer prevalence has largely risen as better survivorship has allowed more patients to live into older adulthood. Total knee arthroplasty (TKA) is a widely performed and increasingly common procedure for end-stage arthritis, and while 90-day outcomes in cancer patients have been described, little is known about outcomes beyond five years. Given the known effects of cancer on bone structure and immunity, this study evaluated implant survival and functional outcomes at five years post-TKA in patients who had cancer compared with a matched cancer-free cohort. METHODS: A retrospective cohort analysis was conducted with a large national database. All adult patients undergoing TKA between July 2002 and July 2020 were identified and grouped by cancer history at the time of surgery. Cohorts were propensity score-matched 1:1 to mitigate differences in baseline demographics and comorbidities. The database identified 134,358 total patients undergoing TKA, of whom 8,937 had a current or previous diagnosis of cancer. After matching, each cohort consisted of 8,709 patients. The primary outcomes at five years included periprosthetic fracture, infection, aseptic loosening, instability, osteolysis, polyethylene wear, myositis ossificans, postoperative pain due to implant, fibrosis due to implant, heterotopic ossification, stiffness, and other instability. Odds ratios (OR) with 95% confidence intervals (CI) were calculated. RESULTS: At five years, patients who had cancer had significantly higher odds of infection due to prosthesis (2.60 versus 2.10%; OR 1.22, 95% CI: 1.00 to 1.48), aseptic loosening (1.10 versus 0.80%; OR 1.36, 95% CI: 1.00 to 1.83), and stiffness (5.00 versus 3.30%; OR 1.56, 95% CI: 1.34 to 1.81). There were no significant differences observed for other complications. CONCLUSIONS: A history of cancer was associated with increased 5-year risk of periprosthetic infection, aseptic loosening, and stiffness after TKA. These findings highlight the need for tailored perioperative optimization, infection prophylaxis, and structured long-term surveillance in this high-risk population.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Deliwala IH, Liu AT, Bank NC, et al. The Five-Year Outcomes of Total Knee Arthroplasty in Patients Who Have Cancer. J Arthroplasty. 2026. PMID: 41655719. doi:10.1016/j.arth.2026.02.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。